Skip to main content

Advertisement

Table 1 Baseline characteristics of the sample according to sex

From: Validation of continuous clinical indices of cardiometabolic risk in a cohort of Australian adults

Characteristic Men (n = 1898) Women (n = 2095) P value Total (n = 3993)
Age (years) 50.80 (16.76) 50.20 (16.05) 0.25 50.49 (16.39)
Weight (kg) 85.32 (15.98) 72.25 (15.74) <0.0001 78.46 (17.38)
Waist girth (cm) 98.43 (13.03) 87.09 (14.12) <0.0001 92.47 (14.74)
BMI (kg/m2) 27.89 (4.78) 27.75 (6.04) 0.41 27.82 (5.48)
Overweight (BMI 25.00 – 29.99 kg/m2)1 874 (46.05%) 663 (31.65%) <0.0001 1537 (38.49%)
Obese (BMI ≥ 30 kg/m2)1 512 (26.98%) 632 (30.17%) 0.03 1144 (28.65%)
Glucose (mmol/L)2 5.1 (4.8-5.6) 4.9 (4.5-5.3) <0.0001 5.00 (4.6-5.5)
Triglycerides (mmol/L)2 1.3 (0.9-2.0) 1.1 (0.8-1.6) <0.0001 1.20 (0.9-1.8)
HDL cholesterol (mmol/L)2 1.2 (1.0-1.4) 1.5 (1.2-1.7) <0.0001 1.30 (1.1-1.6)
Total cholesterol (mmol/L)2 5.1 (4.4-5.8) 5.2 (4.6-6.0) 0.0001 5.2 (4.5-5.9)
Systolic blood pressure (mmHg) 130.90 (17.61) 125.50 (19.15) <0.0001 128.03 (18.63)
Diastolic blood pressure (mmHg) 82.65 (9.96) 78.79 (10.04) <0.0001 80.63 (10.19)
Mean arteriole pressure (mmHg) 98.72 (11.20) 94.35 (11.89) <0.0001 96.43 (11.77)
Metabolic syndrome (ATPIII)1 553 (29.14%) 461 (22.00%) <0.0001 1014 (25.39%)
Type 2 diabetes1 218 (11.49%) 170 (8.11%) 0.0003 388 (9.72%)
Cardiovascular disease1 199 (10.48%) 120 (5.73%) <0.0001 319 (7.99%)
Cardiometabolic disease1 363 (19.13%) 251 (11.98%) <0.0001 614 (15.38%)
  1. Mean (SD) t-test; 1proportions and Chi square; 2median (Q1-Q3) and Wilcoxon Signed Rank.
  2. Abbreviations: BMI Body mass index, ATPIII Adult Treatment Panel III definition.